1. Ma W. H.#, Sun Y.C.#, Yan R.H., Zhang P.G., Shen S.Q., Lu H., Zhou Z.L., Jiang Z.T., Ye L., Mao Q.K., Xiong N.C., Jia W.D., Sun L.C., Gao P. * and Zhang H.F.* (2024). “OXCT1 functions as a succinyltransferase, contributing to hepatocellular carcinoma via succinylating LACTB.” Molecular cell 84: 1-14.
2.Ma W. H.#, Sun Y.C.#, and Zhang H.F.*(2024) “Protocol for identifying OXCT1-mediated LACTB succinylation sites in vitro.” STAR Protocols. 5(2):103088.
3.Wei H. R.#, Ma W. H.#, Lu X.F., Liu H.Y., Lin K.S., Wang Y.H., Ye Z.J., Sun L.C., Huang Z.T., Pan T.T., Zhou Z.L., Cheng E.R., Zhang H.F., Gao P.* and Zhong X.Y.* (2021). “KDELR2 promotes breast cancer proliferation via HDAC3-mediated cell cycle progression.” Cancer Communications 41(9): 904-920.
4.Xing, S.G#, Z. Li#, Ma W. H.#, He X.P.#, Shen S.Q., Wei H.R., Li S.T., Shu Y., Sun L.C., Zhong X.Y., Huangfu Y.H., Su L.H., Feng J.R., Zhang X.Z, Gao P., Jia W.D.* and Zhang H.F.* (2019). “DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing.” Cancer Research 79(19): 4923-4936.
5.Liu, Z. J.#, Sun L.C.#, Cai Y.P.#, Shen S.Q., Zhang T., Wang N.N., Wu G.W., Ma W. H., Li S.T., Suo C.X., Hao Y.J., Jia W.D., G. L. Semenza, Gao P.* and Zhang H.F.* (2021). "Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1." Cancer Research 81(5): 1265-1278.
6.Feng J.R.#, Lu H.#, Ma W. H., Tian W.J., Lu Z., Yang H.M., Cai Y.P., Cai P.F., Sun Y.C., Zhou Z.L., Feng J.Q., Deng J.Z., Shu Y., Qu K., Jia W.D.*, Gao P.* and Zhang H.F.* (2022). "Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer." Protein & Cell 13(11):825-841.
7.Yan R.H.#, Zhang P.G.#, Shen S.Q., Zeng Y., Wang T., Chen Z.L., Ma W.H., Feng J.R., Suo C.X., Zhang T., Wei H. R., Jiang Z.T., Chen R., Li S.T., Zhong X.Y., Jia W.D., Sun L.C., Cang C.L., Zhang H.F.* and Gao P.* (2024). Carnosine regulation of intracellular pH homeostasis promotes lysosome-dependent tumor immunoevasion. Nature Immunology 25(3):483-495.
8.Zhang T.#, Sun L.C.#, Hao Y.J., Suo C.X., Shen S.Q., Wei H.R., Ma W. H., Zhang P.G, Wang T., Gu X.M., Li S.T., Chen Z.L., Yan R.H., Zhang Y., Cai Y.P., Zhou R.B., Jia W.D., Huang F., Gao P. and Zhang H.F. (2022). "ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1." Nature Cancer 3(1): 75-89.
9.Wang T.#, Zhou Y.L.#, Zhou Z.L.#, Zhang P.G., Yan R.H., Sun L.C., Ma W.H., Zhang T., Shen S.Q., Liu H.Y., Lu H., Ye L, Feng J.R., Chen Z.L., Zhong X.Y., Wu G., Cai Y.P., Jia W.D., Gao P.*, Zhang H.F.* (2024). Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps. Nature Communications 18;14(1):1513.
